Paper9568682
Basal hepatic glucose production is regulated by the portal vein insulin concentration.
Sindelar DK and 5 others. Diabetes, 1998. Cited by 110 papers, by iCite.
Cite this record
ConductScience Library. Basal hepatic glucose production is regulated by the portal vein insulin concentration. Papers, record 9568682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9568682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucose | Major topic |
| Insulin | Major topic |
| Liver | Major topic |
| Portal Vein | Major topic |
| Animals | |
| Blood Glucose | |
| Dogs | |
| Fasting | |
| Female | |
| Hepatic Artery | |
| Infusions, Intravenous | |
| Male | |
| Regional Blood Flow |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 2RO1-DK-18243 | NIDDK NIH HHS | United States | R01DK018243 | PubMed and NIH | NIH RePORTER |
| 5P60-DK-2059 | NIDDK NIH HHS | United States | PubMed | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 110 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38298268 | Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/38298268 | PubMed |
| 34477204 | Somatostatin Receptor Antagonism Reverses Glucagon Counterregulatory Failure in Recurrently Hypoglycemic Male Rats. | Endocrinology | 2021 | https://conductscience.org/library/papers/34477204 | PubMed |
| 34203830 | Role of Insulin in Health and Disease: An Update. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34203830 | PubMed |
| 33550986 | Intrauterine growth restriction alters nutrient metabolism in the intestine of porcine offspring. | J Anim Sci Biotechnol | 2021 | https://conductscience.org/library/papers/33550986 | PubMed |
| 32374825 | Novel Insights Into Effects of Cortisol and Glucagon on Nocturnal Glucose Production in Type 2 Diabetes. | J Clin Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32374825 | PubMed |
| 32208001 | The kinetics of glucagon action on the liver during insulin-induced hypoglycemia. | Am J Physiol Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32208001 | PubMed |
| 32144165 | Increase in Endogenous Glucose Production With SGLT2 Inhibition Is Unchanged by Renal Denervation and Correlates Strongly With the Increase in Urinary Glucose Excretion. | Diabetes Care | 2020 | https://conductscience.org/library/papers/32144165 | PubMed |
| 30216981 | The Flavonoid Kaempferol Ameliorates Streptozotocin-Induced Diabetes by Suppressing Hepatic Glucose Production. | Molecules | 2018 | https://conductscience.org/library/papers/30216981 | PubMed |
| 29614722 | Dietary Flavonoids in the Prevention of T2D: An Overview. | Nutrients | 2018 | https://conductscience.org/library/papers/29614722 | PubMed |
| 29042645 | Effects of intranasal insulin application on the hypothalamic BOLD response to glucose ingestion. | Sci Rep | 2017 | https://conductscience.org/library/papers/29042645 | PubMed |
| 28512154 | Glucose autoregulation is the dominant component of the hormone-independent counterregulatory response to hypoglycemia in the conscious dog. | Am J Physiol Endocrinol Metab | 2017 | https://conductscience.org/library/papers/28512154 | PubMed |
| 28352665 | Insulin's direct hepatic effect explains the inhibition of glucose production caused by insulin secretion. | JCI Insight | 2017 | https://conductscience.org/library/papers/28352665 | PubMed |
| 28084015 | Plasma mannose level, a putative indicator of glycogenolysis, and glucose tolerance in Japanese individuals. | J Diabetes Investig | 2017 | https://conductscience.org/library/papers/28084015 | PubMed |
| 27298249 | Hepatic and Whole-Body Insulin Metabolism during Proestrus and Estrus in Mongrel Dogs. | Comp Med | 2016 | https://conductscience.org/library/papers/27298249 | PubMed |
| 25200294 | Control of hepatic glucose metabolism by islet and brain. | Diabetes Obes Metab | 2014 | https://conductscience.org/library/papers/25200294 | PubMed |
| 24947349 | Changes in glucose and fat metabolism in response to the administration of a hepato-preferential insulin analog. | Diabetes | 2014 | https://conductscience.org/library/papers/24947349 | PubMed |
| 24089512 | Novel PEGylated basal insulin LY2605541 has a preferential hepatic effect on glucose metabolism. | Diabetes | 2014 | https://conductscience.org/library/papers/24089512 | PubMed |
| 23959343 | Insulin and glucagon signaling in the central nervous system. | Rev Endocr Metab Disord | 2013 | https://conductscience.org/library/papers/23959343 | PubMed |
| 22847060 | Elevated NEFA levels impair glucose effectiveness by increasing net hepatic glycogenolysis. | Diabetologia | 2012 | https://conductscience.org/library/papers/22847060 | PubMed |
| 22456868 | Estimating hepatic glucokinase activity using a simple model of lactate kinetics. | Diabetes Care | 2012 | https://conductscience.org/library/papers/22456868 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9568682
GET https://conductscience.org/api/papers/v1/9568682/cited_by?page=2